Comparison Chart Annexin Pharmaceuticals AB
Stocks
ANNX
SE0025159387
Biotechnology & Medical Research
|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 12.55 SEK | -1.95% |
|
+2.03% | -36.62% |
| 07-21 | Annexin Pharmaceuticals Updates on Nine Patients Treated in Nexus Study | CI |
| 07-16 | Calendar, Thursday, July 16 | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Bio Therapeutic Drugs | -1.95% | +2.03% | -36.62% | -57.02% | -93.65% | 9.46M |  |  | |
- Stock Market
- Stocks
- ANNX Stock
- Charts Annexin Pharmaceuticals AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
